Search Results - Laura Stanbery

HER2-positive metastatic cervical cancer responsive to first and second-line treatment: A case report by Dylan Fortman, Rochell Issa, Laura Stanbery, Mary Albrethsen, John Nemunaitis, Timothy Kasunic

Connect to this object online.

Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer by John Nemunaitis, Laura Stanbery, Adam Walter, Adam Walter, Rodney Rocconi, Philip Stephens, Philip Stephens

Connect to this object online.

Adenomatous polyposis coli in cancer and therapeutic implications by Olivia Noe, Louis Filipiak, Rachel Royfman, Austin Campbell, Leslie Lin, Danae Hamouda, Laura Stanbery, John Nemunaitis

Connect to this object online.

Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (202... by Jonathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi

Connect to this object online.

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance by Johnathan Oh, Minal Barve, Neil Senzer, Phylicia Aaron, Luisa Manning, Gladice Wallraven, Ernest Bognar, Laura Stanbery, Staci Horvath, Meghan Manley, John Nemunaitis, Adam Walter, Rodney P. Rocconi

Connect to this object online.